Immatics (IMTX) Net Income (2019 - 2025)
Immatics (IMTX) reported Net Income of -$41.6 million for Q4 2025, down 195.42% on a YoY basis from $43.6 million in Q4 2024, and up 29.68% sequentially from -$59.1 million in Q3 2025.
Immatics (IMTX) Net Income (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Net Income data on file, last reported at -$41.6 million in Q4 2025.
- For the quarter ending Q4 2025, Net Income fell 195.42% year-over-year to -$41.6 million; the trailing twelve-month figure through Dec 2025 stood at -$222.2 million (down 1496.09% YoY), and the FY2025 full-year result was -$221.9 million, down 1447.51% from the prior year.
- Net Income grew to -$41.6 million in Q4 2025, from -$59.1 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $96.1 million in Q1 2022 to a low of -$148.5 million in Q3 2021.
- A 5-year average of -$13.4 million and a median of -$19.3 million in 2021 frame the typical range for Net Income.
- Across the five-year window, Net Income jumped 663.89% in 2023 and tumbled 1622.77% in 2025, its largest moves.
- Tracing IMTX's Net Income over 5 years: stood at -$19.2 million in 2021, then increased by 29.7% to -$13.5 million in 2022, then surged by 663.89% to $76.1 million in 2023, then slumped by 42.79% to $43.6 million in 2024, then tumbled by 195.42% to -$41.6 million in 2025.
- Business Quant data shows IMTX's Net Income at -$41.6 million in Q4 2025, -$59.1 million in Q3 2025, and -$79.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | -41.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41.55 Mn |
| Sep 30, 2025 | -59.09 Mn |
| Jun 30, 2025 | -79.63 Mn |
| Mar 31, 2025 | -41.92 Mn |
| Dec 31, 2024 | 43.55 Mn |
| Sep 30, 2024 | -5.82 Mn |
| Jun 30, 2024 | -19.38 Mn |
| Mar 31, 2024 | -2.43 Mn |
| Dec 31, 2023 | 76.12 Mn |
| Sep 30, 2023 | -125.41 Mn |
| Jun 30, 2023 | 69.80 Mn |
| Mar 31, 2023 | -21.20 Mn |
| Dec 31, 2022 | -13.50 Mn |
| Sep 30, 2022 | -21.11 Mn |
| Jun 30, 2022 | -14.92 Mn |
| Mar 31, 2022 | 96.14 Mn |
| Dec 31, 2021 | -19.20 Mn |
| Sep 30, 2021 | -148.47 Mn |
| Jun 30, 2021 | 86.90 Mn |
| Mar 31, 2021 | -27.52 Mn |